Teva calls on startups to Rise to the occasion with open innovation platform for 7 biopharma challenges
7.0
来源：
FiercePharma
发布时间：
2025-11-18 16:15
摘要：
Teva Pharmaceutical Industries has launched its first global innovation platform, Teva Rise, inviting startups to propose solutions for seven key challenges in the biopharma industry, including clinical trial design and patient experience. The initiative is part of Teva's 'Pivot to Growth' strategy, with plans to invest tens of millions in selected projects. Startups will have the opportunity to showcase their technologies and receive mentorship, aiming to enhance efficiency and patient outcomes in drug development.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+重点关注领域符合度
business_impact
1.0分+商业影响力
scientific_rigor
1.0分+数据支撑的科学性
timeliness_innovation
1.5分+时效性与创新性
investment_perspective
2.5分+BOCG投资视角
market_value_relevance
1.0分+市场价值相关性
team_institution_background
0.0分+团队与机构背景
technical_barrier_competition
0.0分+技术壁垒与竞争格局
关键证据
Teva expects to collect at least 100 applications from startups.
The initiative aims to introduce and accelerate novel solutions.
Teva plans to commit tens of millions of dollars to the potential solutions.
真实性检查
否
AI评分总结
Teva Pharmaceutical Industries has launched its first global innovation platform, Teva Rise, inviting startups to propose solutions for seven key challenges in the biopharma industry, including clinical trial design and patient experience. The initiative is part of Teva's 'Pivot to Growth' strategy, with plans to invest tens of millions in selected projects. Startups will have the opportunity to showcase their technologies and receive mentorship, aiming to enhance efficiency and patient outcomes in drug development.